Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$60K
Filings
100
Firms Hired
3
Active Period
2007–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 - Saving Access to Laboratory Services Act (SALSA); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: H.R. 10445
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to clinical diagnostic laboratory services; issues related to public health emergency preparedness; H.R. 3975 - The Diagnostics Testing Preparedness Plan; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: H.R. 10445
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 - Saving Access to Laboratory Services Act (SALSA); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1691
Saving Access to Laboratory Services Act
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 - Saving Access to Laboratory Services Act (SALSA); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: HR 2377
IT Service Corps Act
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to clinical diagnostic laboratory services; issues related to public health emergency preparedness; H.R. 3975 - The Diagnostics Testing Preparedness Plan; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3975
Saving Access to Laboratory Services Act
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 - Saving Access to Laboratory Services Act (SALSA); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; H.R. 10445 - Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $30,000
Matched citations: S.1000
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1691
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: HR 2377
Saving Access to Laboratory Services Act
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S.1000
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1691
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: HR 2377
Telehealth Modernization Act of 2024
2024 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7623
Saving Access to Laboratory Services Act
2024 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S.1000 / HR 2377 Saving Access to Laboratory Services Act (SALSA); H.R. 7623-Telehealth Modernization Act of 2024 regarding phase-in of Medicare clinical laboratory test payment; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S.1000
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1691
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act, S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2369
Saving Access to Laboratory Services Act
2024 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2377
Saving Access to Laboratory Services Act
2024 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1000
Pandemic and All-Hazards Preparedness and Response Act
2024 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to clinical diagnostic laboratory services; H.R. 2369 The Verifying Leading-edge IVCT Development Act, S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness.
Client expense: — · Firm income: $30,000
Matched citations: S. 2333
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1691
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2377
Consolidated Appropriations Act, 2024
2023 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Year 2024 Minibus Appropriations relating to laboratory developed tests.
Client expense: — · Firm income: $30,000
Matched citations: HR 4366
Saving Access to Laboratory Services Act
2023 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1000/H.R. 2377 Saving Access to Laboratory Services (SALSA); H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: S. 1000
Pandemic and All-Hazards Preparedness and Response Act
2023 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Year 2024 Minibus Appropriations relating to laboratory developed tests.
Client expense: — · Firm income: $30,000
Matched citations: S. 2333
Source: Senate LDA